×
Analysis of the QTc Interval During Olanzapine Treatment of Patients With Schizophrenia and Related Psychosis PDF
$ 40.00
Analysis of the QTc Interval During Olanzapine Treatment of Patients With Schizophrenia and Related Psychosis PDF quantity
$ 40.00
×
Metabolic Health of People Admitted to a Psychiatric Intensive Care Unit in Adelaide, South Australia PDF
$ 40.00
Metabolic Health of People Admitted to a Psychiatric Intensive Care Unit in Adelaide, South Australia PDF quantity
$ 40.00
×
Prompt Use of Benzodiazepines for Anxiety Management in COVID-19-Positive Patients With Tracheostomy PDF
$ 40.00
Prompt Use of Benzodiazepines for Anxiety Management in COVID-19-Positive Patients With Tracheostomy PDF quantity
$ 40.00
×
Clinical Outcome After Antipsychotic Treatment Discontinuation in Functionally Recovered First-Episode Nonaffective Psychosis Individuals: A 3-Year Naturalistic Follow-Up Study PDF
$ 40.00
Clinical Outcome After Antipsychotic Treatment Discontinuation in Functionally Recovered First-Episode Nonaffective Psychosis Individuals: A 3-Year Naturalistic Follow-Up Study PDF quantity
$ 40.00
×
Toxic Effects of Psychotropics Related to Possible P450 Enzyme Inhibition by Kava: Report of 2 Cases PDF
$ 40.00
Toxic Effects of Psychotropics Related to Possible P450 Enzyme Inhibition by Kava: Report of 2 Cases PDF quantity
$ 40.00
×
A Review of Dextromethorphan-Quinidine for the Treatment of Agitation in Dementia PDF
$ 40.00
A Review of Dextromethorphan-Quinidine for the Treatment of Agitation in Dementia PDF quantity
$ 40.00
×
Metabolic Syndrome and the Risk of Coronary Heart Disease in 367 Patients Treated With Second-Generation Antipsychotic Drugs. PDF
$ 40.00
Metabolic Syndrome and the Risk of Coronary Heart Disease in 367 Patients Treated With Second-Generation Antipsychotic Drugs. PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart